Oral Ketamine - Neurocentrx Pharma
Alternative Names: KeticapLatest Information Update: 14 Oct 2025
At a glance
- Originator Neurocentrx Pharma
- Class Amines; Analgesics; Antidepressants; Antihyperglycaemics; Antiparkinsonians; Anxiolytics; Behavioural disorder therapies; Chlorobenzenes; Cyclohexanes; General anaesthetics; Ketones; Mood stabilisers; Neuroprotectants; Neuropsychotherapeutics; Obesity therapies; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes - Anorexia nervosa
Highest Development Phases
- Phase I Mood disorders